Jonathan D. Tward

Jonathan D. Tward is a tenured Professor in the Department of Radiation Oncology at the University of Utah and directs the Huntsman Cancer Institute (HCI) Genitourinary Cancers Center (GUCC). With expertise in prostate, bladder, and penile cancers, he pioneers AI-driven digital-molecular oncology through innovations in precision radiation therapy, multimodal imaging, and prognostic biomarker development.

• Education: BS in Biology (UCLA), PhD in Biochemistry, MD (Tufts University), Residency in Radiation Oncology (University of Utah)
• Leadership: Director of GUCC, Utah ASTRO State Captain, NCCN Guideline Panel Member

His research integrates machine learning with genomic/transcriptomic profiling to optimize radiation workflows and validate molecular signatures in clinical trials. He is a globally recognized authority in AI-enabled cancer discovery and digital pathology, holding the Vincent P. and Janet Mancini Endowed Chair. Dr. Tward’s work emphasizes resource-stratified oncology solutions for low/middle-income settings.

Scientific awards include the Vincent P. and Janet Mancini Presidential Endowed Chair and Fellowship in the American Society for Radiation Oncology (FASTRO). His 100+ peer-reviewed publications focus on AI-guided treatment adaptation, cell-cycle risk modeling, and multimodal prognostication in GU malignancies. Patient testimonials highlight his empathetic care, technical precision, and global leadership in radiation oncology.